A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Mycophenolate sodium (Primary) ; Calcineurin inhibitors; Mycophenolate mofetil; Prednisone
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- Acronyms AUC-MPA
- 01 Apr 2015 According to the ClinicalTrials.gov record, status changed from not yet recruiting to completed.
- 10 Apr 2013 New trial record